We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+13.36%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.76B
AUM Growth
+$158M
Cap. Flow
+$12.9M
Cap. Flow %
0.73%
Top 10 Hldgs %
26.37%
Holding
139
New
12
Increased
27
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
ELLI
Ellie Mae Inc
ELLI
+$22.2M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$16.2M
4
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.2M
5
FIVN icon
FIVE9
FIVN
+$12.5M

Top Sells

Rank Stock Value
1
LOXO
Loxo Oncology, Inc
LOXO
+$19M
2
BLUE
bluebird bio
BLUE
+$17M
3
SPLK
Splunk Inc
SPLK
+$10.6M
4
PFPT
Proofpoint, Inc.
PFPT
+$9.51M
5
KITE
Kite Pharma, Inc.
KITE
+$8.81M

Sector Composition

Rank Sector Weight
1 Healthcare 38.21%
2 Technology 13.87%
3 Consumer Discretionary 13.68%
4 Industrials 7.76%
5 Utilities 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOXO
26
DELISTED
Loxo Oncology, Inc
LOXO
$26.3M 1.49%
285,000
-245,000
-46% -$19M
AIMT
27
DELISTED
Aimmune Therapeutics
AIMT
$25.5M 1.45%
1,030,000
– –
FPRX
28
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$24.6M 1.39%
601,000
– –
XLRN
29
DELISTED
Acceleron Pharma
XLRN
$24.4M 1.38%
653,900
– –
SNA icon
30
Snap-on
SNA
$21.2B
$24.4M 1.38%
163,500
+3,500
+2% +$526K
ARW icon
31
Arrow Electronics
ARW
$10.9B
$23.7M 1.34%
295,000
– –
COLL icon
32
Collegium Pharmaceutical
COLL
$1.17B
$23.2M 1.31%
2,207,610
– –
IPHI
33
DELISTED
INPHI CORPORATION
IPHI
$22M 1.25%
555,000
– –
SPLK
34
DELISTED
Splunk Inc
SPLK
$22M 1.25%
331,000
-169,000
-34% -$10.6M
IDTI
35
DELISTED
Integrated Device Technology I
IDTI
$22M 1.24%
826,000
– –
CAFD
36
DELISTED
8point3 Energy Partners LP
CAFD
$21.9M 1.24%
1,458,600
-12,500
-0.8% -$182K
PEGI
37
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$21.6M 1.22%
895,000
+9,000
+1% +$224K
ELLI
38
DELISTED
Ellie Mae Inc
ELLI
$19.9M 1.13%
+242,000
New +$22.2M
CRUS icon
39
Cirrus Logic
CRUS
$6.65B
$19.7M 1.12%
370,000
– –
VCYT icon
40
Veracyte
VCYT
$4.77B
$18.7M 1.06%
2,133,500
– –
HUBS icon
41
HubSpot
HUBS
$11.9B
$17.5M 0.99%
208,000
– –
HASI icon
42
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$17.2M 0.97%
705,000
+5,000
+0.7% +$117K
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$16.4M 0.93%
236,000
-29,000
-11% -$1.55M
AY
44
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$15.9M 0.9%
808,000
-146,000
-15% -$3.03M
DOOR
45
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$15.6M 0.88%
225,000
-125,000
-36% -$8.62M
APTV icon
46
Aptiv
APTV
$12.3B
$15.5M 0.88%
158,000
– –
AGIO icon
47
Agios Pharmaceuticals
AGIO
$1.95B
$14.3M 0.81%
214,000
-86,800
-29% -$5.21M
CYBR
48
DELISTED
CyberArk
CYBR
$14M 0.79%
342,000
-208,000
-38% -$8.81M
PFPT
49
DELISTED
Proofpoint, Inc.
PFPT
$13.8M 0.78%
158,000
-107,000
-40% -$9.51M
FIVN icon
50
FIVE9
FIVN
$2.12B
$13.8M 0.78%
+576,000
New +$12.5M
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Eventide Asset Management held 139 positions worth $1.76B, up 9.9% from $1.61B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management's Q3 2017 filing shows 12 new, 27 increased, 23 reduced and 3 closed positions. Its largest new stake was Ellie Mae Inc: 242,000 shares worth $19.9M. The largest sale was Loxo Oncology, Inc, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q3 2017 buy was Ellie Mae Inc: 242,000 shares worth $19.9M.
  • Eventide Asset Management added most to Vertex Pharmaceuticals in Q3 2017, an estimated $21.9M increase.
  • Eventide Asset Management's biggest Q3 2017 reduction was Loxo Oncology, Inc, cutting an estimated $19M.
  • Eventide Asset Management fully exited Kite Pharma, Inc. in Q3 2017, selling an estimated $8.81M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $1.76B portfolio in Q3 2017.
  • Eventide Asset Management opened 12 new positions and closed 3 in Q3 2017.
  • Eventide Asset Management's portfolio value rose 9.9% quarter-over-quarter to $1.76B.

Based on Eventide Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.